chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received vaccine,while scheduling next appointment got hot , heart felt like it was pounding, felt like her throat was slightly tight.  She immediately took a benadryl from her purse.  When writer arrived client's B/P was 150/78 heart rate 98.  Respirations even and unlabored.  Skin pink,warm and dry.  Client was kept for further monitoring. Upon discharge B/P 110/68 no signs or symptoms of distress.  Informed to seek medical advice if any further problems.
Arm soreness - 48 hours Fatigue/body aches - 36 hours Fever - 24 hours Nausea - 12 hours Headache - 40hours Backache - 40 hours
Small raised bump on skin at injection site. Approximately 2 weeks after injection (8/31), it was noticed.
Proquad was given instead of MMR vaccine. Therefore, the patient received 2 Varicella vaccines (a double dose)
diagnosed with COVID-19; This is a spontaneous report received from a contactable consumer (patient) via medical information team. A 40-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on 09Apr2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 12Apr2021, the patient was diagnosed with covid-19. patient states that she was re-tested on Monday 26Apr2021 which came back negative. Patient also reported that her husband, who received his first dose the same day as her, already had COVID-19 before receiving the vaccine. Patient would like to know if she and her husband are okay to receive their second doses of the vaccine tomorrow. The patient underwent lab tests and procedures on 26Apr2021, sars-cov-2 antibody test negative. No PQC present. The outcome of the event was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt is 2mo pregnant, diabetic was seen yesterday had her flu shot, about 1 hour after injection she began feeling bad and itching all over, approx 3hrs later began having hives all over body.
severe pain in lt arm & upper back pain & shoulders painful; shooting down arms to fingers x 15 days; hx of scar tissue on upper lt arm;
12:00 AM woke with severe jaw pain on left side. Unable to fully open mouth. Body was uncontrollably trembling all over. No fever/chill feeling but full tremors occurring throughout body for 30 minutes. After 30 minutes the shaking subsided significantly. Residual jaw pain still present 20 hours later
EXTReMe TiRedNess, MuscLe FATigue, PaiN, H/A Nausea, ? Fever, Slept greater than 12 hRs, Eyes Burning
Patient reported to emergency room at  Community Hospital on 1/26/21 AM after receiving second dose of Moderna's COVID-19 Vaccine on 1/25/21.  She reported feeling weak, having nausea, and having a headache and believed she was having a reaction to the vaccine.  She was ordered Zofran PO and Ibuprofen PO by the emergency room physician and discharged home.
At 6pm on Feb 19, I was very cold no matter how many layers of clothing I put on. Around 8pm I started getting chills and a headache. Around 10pm I almost fainted going up the stairs (I turned white and felt the blood drain from my face, I got very dizzy and had to sit down with supervision). I woke up at 12:30am and had a fever of 101 F and took some acetometaphine to hopefully lower my fever. I checked my temperature again at 8:30am this morning (feb 20) and was at 99.5 F and a slight headache.
Information has been received from a certified medical assistant concerning a 4 year old female with no medical history or drug allergies, who on 13-SEP-2004 and 09-AUG-2007 was vaccinated with her first and second (lot# 655345/1323F) dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no concomitant medication. On 09-AUG-2007, the patient was administered her second dose intramuscularly in the right arm and the patient developed a small, red, swollen, and painful area at the injection site. The patient sought medical attention through the physician's office on 31-AUG-2007. No labs or diagnostic studies were performed. On that same day, the patient was recovered. There was no product quality complaint. Additional information has been requested.
Patient states the morning after Tdap administer she awoke with right eye swollen - took a Benadryl with no change went to MD - by now, both eyes swollen and she was wheezing - took "breathing treatment" with no change to where she received "a shot' - stayed overnight, better now. Was told "probable reaction to preservatives".  08/03/2007 MR received for ER visit DOS 7/10/07 for c/o worsening eyelid swelling, wheezing and cough. PE (+) for Swollen eye lids, red forehead, nasal bridge swollen. Assessment: Allergic reaction to Td. Anaphylaxis NOS. Elevated BP without DX of HTN.
Shortly after, his arm began to hurt  and became red/hot pink and hurt to touch it. His arm also became very swollen. It hurt for him to lift his arm or use it. It was also hot to touch it. This lasted for 3-4 days.
Pt recv vax on 11/12/98; on 11/14/98 pt exp fever (105F)
Aleve, rest. Slept almost 24 hours. Symptoms lasted about 36 hours
Severe cough and cold after the first dose; Severe cough and cold after the first dose; This is a spontaneous report from a contactable Consumer (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on Jan2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated she received the first dose of the vaccine 3 weeks ago and is due for her second dose tomorrow morning. Patient stated in the past week ended up getting sick. The patient experienced a severe cough and cold after the first dose on an Unspecified date Jan2021. The patient tested negative for Covid on 10Feb2021. Patient stated she is getting conflicting information about whether she should receive the vaccine tomorrow. She just wants to know if she will take the second shot. The event outcome was Unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a consumer refers to a her 5 years old son who on an unknown date was vaccinated with a dose of oral ROTATEQ (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The patient's mother stated that while on oral ROTATEQ her son did not eat eggs any longer. He also had unspecified bowel issues. No treatment was given for the experience. At the time of the report, the patient had not recovered. The relatedness for patient did not eat eggs any longer and patient had unspecified bowel issues was unknown for oral ROTATEQ. This is one of several reports from the same source. Additional information has been requested.
arm sore from test site still after 4 days, sore throat, headache, chills, nausea
This spontaneous report  as received from a Medical Assistant refers to a patient of unknown age and gender. On 03-JUL-2015, the patient was vaccinated with an improperly stored dose of M-M-R II lot # K016154 with exp. 24-SEP-2016, (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
''I'' woke up with a terrible, excruciating headache; ''I'' started puking and could not stop.; Started feeling really bad; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 19Sep2021 at 16:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), major depressive disorder, unspecified psychiatric disorder, panic disorder and unspecified personality disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol (VITAMIN D3), citalopram hydrobromide (CELEXA) and valaciclovir (VALACYCLOVIR), all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and experienced drug allergy. On 21Sep2021, Tuesday at 13:00, the patient started feeling really bad and then on the same day at 16:30, the patient started puking and could not stop. The patient could not hold anything down and it made it worse, she finally stopped puking around 22:00. On 23Sep2021, she woke up with a terrible excruciating headache. She took 3 advils and tried to go back to sleep. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event woke up with a terrible, excruciating headache which included treatment with 3 ibuprofens (ADVIL). The clinical outcome of the event started puking and could not stop was resolved on 21Sep2021 at 22:00 whereas the events feeling really bad and woke up with a terrible, excruciating headache was resolving at the time of this report.
Patient came in for visit. Was seen by MA first and gave LMP of 09/7/19 stating that she had not yet missed her period. Answered no to  vaccine questions and MA administered live vaccine per standing protocol. When provider saw patient and noted that she had fatigue and nausea and vomiting x 1 week, pregnancy test performed. Pregnancy test was positive. Patient then reported that period was likely on 8/20/19.
It was reported that a female pt received Rabies Imovax vaccine on 7/30/99. Reportedly, sometime, post vax, (duration unspecified), the pt experienced a low-grade fever (99.2F), malaise, headache, intermittent joint pain and a feeling of "lump in throat".
Had not received the second / First dose / Engerix-B and Havrix on January 28th 2021; Tested positive for Hepatitis A / on Tuesday 27-jul-2021; Tested positive for Hepatitis A; Tested positive for / Hepatitis B / on Tuesday 27-jul-2021; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a 54-year-old female patient who received HAV (Havrix) (batch number N39BM, expiry date 31st January 2022) for prophylaxis.   Co-suspect products included HBV (Engerix B) (batch number p4dj52156, expiry date 15th December 2022) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis and hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th January 2021, the patient received the 1st dose of Havrix, the 1st dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, the patient received the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On 27th July 2021, 180 days after receiving Havrix, Engerix B and Engerix B Pre-Filled Syringe Device, not applicable after receiving Engerix B, Engerix B Pre-Filled Syringe Device, Engerix B and Engerix B Pre-Filled Syringe Device and not applicable after receiving Engerix B, Engerix B Pre-Filled Syringe Device, Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced vaccination failure (serious criteria GSK medically significant), hepatitis a and hepatitis b (serious criteria GSK medically significant). On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the vaccination failure, hepatitis a, hepatitis b and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the vaccination failure, hepatitis a and hepatitis b to be related to Havrix. It was unknown if the reporter considered the hepatitis a and hepatitis b to be related to Engerix B and Engerix B Pre-Filled Syringe Device.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The patient tested positive for Hepatitis A and Hepatitis B on Tuesday, 27th July 2021 after receiving 1st dose of Havrix and Engerix B, but the reporter thought it might be a false positive. Till the time of reporting, the patient did not receive the 2nd dose Engerix B, which led to incomplete course of vaccination. No further events were reported. The reporter consented to follow up.
Fever, Sweating, clammy, and headache. Started 1/21/21 at 2am. patient reports Fever 104. Patient took tylenol and fever was 102 at 6:30am 1/21/21
THIS CASE MEETS VACCINE BREAKTHROUGH CRITERIA.  PT PRESENTED WITH NAUSEA/VOMITING, CHILLS, FATIGUE.
This spontaneous report was received from a company representative (patient parent) refers to a 11 year old female patient. The patient's pertinent medical history and concurrent conditions were not reported. The patient never had reactions to other unspecified vaccines or flu mists in the past. On 05-OCT-2015, the patient was vaccinated with GARDASIL 9 in the shoulder. Other co suspect therapy included FLUMIST (intranasal (cold). On 06-OCT-2015, 2 days after onset of therapy, the patient experienced headache, low grade fever, stomach ache, debilitating and extreme fatigue. The reporter stated that the main problem was fatigue as the patient was unable to attend school. On an unknown date in October 2015, the patient sought medical attention and was treated with unspecified doses of ibuprofen, ALEVE and TYLENOL all over the counter. On an unknown date in October 2015, the patient has blood work and the results were not reported. On 11-OCT-2015, the patient recovered from headache, low grade fever, stomach ache, debilitating, extreme fatigue and unable to attend school. The reporter did not provide the causality between the events and the suspect therapy. Additional information has been requested.
Patient did not have any adverse reaction, nor any side effects from receiving the 2nd dose. Patient had already received the vaccine for the season, and was accidentally given a second.
mom described sz in early AM (+-3AM) on 13DEC96 shaking & jerking of extremities;almost constant screaming described lasting 4 days;mom felt pt had fever but did not take temp;pt was seen @ MD office;devel resp sx & agitated;dx bronchitis
This spontaneous report as received from a pharmacist via a company representative refers to a male patient of unknown age. No information about the patient's medical history and concurrent conditions was reported. In approximately April 2016 (reported as 'about 6 months ago') the patient was vaccinated with a dose of unspecified pneumococcal vaccine (manufacturer unknown) in his arm (dose, route of administration, lot# and expiry date were not reported)-the reporter stated that it could not be determined if it was PNEUMOVAX 23 or PREVENAR 13. Concomitant therapies were not reported. On an unknown date, the patient experienced redness and swelling around injection site. The patient's entire arm in which vaccine was administered was red. The outcome of adverse events was not reported. The relatedness between the unspecified pneumococcal vaccine (manufacturer unknown) and events was not reported. Additional information has been requested.
injection site was "very warm"; "red spot baseball size"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site was "very warm") and VACCINATION SITE ERYTHEMA ("red spot baseball size") in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A. and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE WARMTH (injection site was "very warm") and VACCINATION SITE ERYTHEMA ("red spot baseball size"). At the time of the report, VACCINATION SITE WARMTH (injection site was "very warm") and VACCINATION SITE ERYTHEMA ("red spot baseball size") outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. No treatment was provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient was ever diagnosed with/ tested positive for COVID-19. It was unknown if patient had acute illnesses at the time of vaccination and up to one month before or chronic/ long-lasting health conditions.     On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Vaccine number 1 NDC code was reported as 80777-0273-99. The patient did not had any adverse reactions after the administration of the vaccines. Pfizer-BioNTech COVID-19 Vaccine (+12) requested.  No treatment medication was reported.
Severe muscle aches spreading from right arm to neck, chest/back area and back of head (including headache).  Aching, fever and chills  lasting approximately 12 hours.  Attempted to sleep for entire day and following night.  Symptoms nearly 100% gone the next morning (08/11/2019)
She has since developed a lump under her skin on the top of her head.; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 39 year-old female patient received bnt162b2 (BNT162B2), administration date 10May2021 (Batch/Lot number: unknown) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN MASS (non-serious) with onset May2021, outcome "unknown", described as "She has since developed a lump under her skin on the top of her head.".  No follow-up attempts are possible. No further information is expected.
Received the new mRNA COVID immunization/booster (my sixth) on 10/2/23. On 10/6 my BP was hard to measure accurately as I was skipping at least every fourth beat with PVCs. On 10/7 I applied a Zio XT heart monitor that my cardiologist had prescribed for me. I wore it for a week during which time I had five more days of significant dizziness and presyncope. When the Zio monitor was analyzed, I had experienced a PVC burden of 25.9%. I continued to have episodes of dizziness from 10/12 through 10/23. Previous history: I had had COVID in 12/22 and during the days that I was most ill, I had fainted (from standing to floor) three times. I received no medication during my illness but did think I had responded to Liquid IV so my cardiologist thought perhaps I was simply dehydrated. I now believe it was the viral effect of COVID on my heart as was demonstrated 10 months later with the mRNA COVID immunization. I have a new Zio XT monitor that I will be applying today (11/2/23) and it will be worn for 14 days. Now that the dizziness is gone, my electrophysiologist cardiologist want to reassess my PVC burden.
First COVID-19 vaccine: right side of her body go numb- it had like that tingling feeling like pins and needles; First COVID-19 vaccine: very sore; First COVID-19 vaccine: nausea; First COVID-19 vaccine: stiffness in her neck and back, on her right side; First COVID-19 vaccine: right side of her body go numb- it had like that tingling feeling like pins and needles; This is a spontaneous report from a contactable consumer (patient). A 30-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: ER6207, patient was 30-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Right on 15Mar2021 at 03:40 PM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included anxiety and depression from 2016 diagnosed probably about 5 years, Chronic migraines from 2019 diagnosed about 2 years, lactose intolerance for 9 years, allergy to latex for as long as she can remember. Probably since birth, anytime someone touches her with latex, she breaks out into hives, ichy after getting a vaccine which was family history, sensitivity to cow milk. There were no concomitant medications. Historical vaccine included flu shot for immunization and experienced chills, mild fever, nausea, feels icky. Most of the other vaccines, she had not really had since she was a child, but she usually gets a mild fever, achy, that is what she remembers. She guesses usually when she gets any vaccine, she feels "icky". Caller states she does have her vaccination card that is from California where she received these vaccinations. All of the childhood vaccinations on her card show when she received it but does not give what type of vaccine or any additional information. Caller confirmed she was not a healthcare provider such as a doctor, pharmacist or nurse at the beginning of the call, although caller later states when probed for indication of the vaccine, she is healthcare worker at a childcare facility. No previous immunization with the Pfizer vaccine considered as suspect. No other vaccinations received within four weeks prior to the first administration date of the suspect vaccine(s). On 15Mar2021, the patient experienced first covid-19 vaccine: right side of her body go numb- it had like that tingling feeling like pins and needles, first covid-19 vaccine: very sore, first covid-19 vaccine: nausea, first covid-19 vaccine: stiffness in her neck and back, on her right side. AE does not require to visit physician office and emergency Room. Reporter that she had not taken anything yet as treatment. She adds she had probably going to take Tylenol since she read on the paper it was safe to take. The outcomes of events were recovered on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.